Medizone International announces terminated CEO, Joseph S. Latino, resigns from the company's board of directors. Contact: Bill Roberts (513) 469-0202 Salt Lake City, Utah - July 9, 1997, - Medizone International, Inc. ("Medizone") (OTC.BB: MZEI.U) announced today that Joseph S. Latino, Ph.D. has resigned from the company's board of directors effective immediately. Dr. Joseph S. Latino was terminated as Medizone's president, chief executive officer and chairman by the company's board on May 14, 1997, but in accordance with the corporation's by-laws, he remained a member of the medizone board of directors. Replacing Latino as president and full time chief executive officer is Milton G. Adair (64) who brings over 30 years experience in the biomedical field. Prior to joining Medizone, Adair was president and chief executive officer of Biomune Systems (NASDAQ: BIME), and international company specializing in nutritional aids products. He held this position since January 1996. From September 1991 to January 1996, Adair was president and chief executive officer of Gull Laboratories (AMEX:GUL), an international diagnostic company with a primary focus in the infectious disease market. Adair had also served as president and chief executive officer of Mountain Medical Equipment Company and Orbit Medical Systems (a venture company in immunochemistry) as well as serving as an FDA liason officer to ensure compliance on new drug applications and labeling. Medizone is developing the utilization of thin film technology in the application of ozone for the decontamination of blood and blood products as well as for therapeutic treatment of certain diseases caused by lipid enveloped viruses, including Aquired Immunodeficiency Syndrome (Aids), Hepatitis B, Herpes and Epstein Barr. Medizone is a development state company.